Company Performance Metrics
Established in April 2003, BIONIME is specialized in the business of biotechnology and medical testing. The first product line is the Self Monitoring Blood Glucose (SMBG) System. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patented technology of unique test strip
structure.Today, BIONIME operates 4 subsidiaries in major markets, Europe, America, and China. Their products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed in the worldwide markets. With the support from their customers, they are confident to grow BIONIME the global competitive leadership in the field of SMBG (Self-Monitor Blood Glucose).
